The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2009

Filed:

Aug. 30, 2004
Applicants:

Martha Kelly, Collegeville, PA (US);

Bruce D. Dorsey, Ambler, PA (US);

Gary A. Flynn, Tucson, AZ (US);

Inventors:

Martha Kelly, Collegeville, PA (US);

Bruce D. Dorsey, Ambler, PA (US);

Gary A. Flynn, Tucson, AZ (US);

Assignee:

Locus Pharmaceuticals, Inc., Blue Bell, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); A61K 31/4439 (2006.01); A61K 31/421 (2006.01); A61K 31/404 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 413/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein Ais N or CR; Ais N or CR; Ais N or CR; R, R-Rand L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur. They are effective against a broad range of cancers, especially leukemia, non-small cell lung and colon.


Find Patent Forward Citations

Loading…